Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24998473)

1.

Tumor characteristics of breast cancer in predicting axillary lymph node metastasis.

Tseng HS, Chen LS, Kuo SJ, Chen ST, Wang YF, Chen DR.

Med Sci Monit. 2014 Jul 7;20:1155-61. doi: 10.12659/MSM.890491.

2.

Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.

Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP.

J Am Coll Surg. 2000 Jul;191(1):1-6; discussion 6-8.

PMID:
10898177
3.

Frequency and predictors of axillary lymph node metastases in invasive breast cancer.

Chua B, Ung O, Taylor R, Boyages J.

ANZ J Surg. 2001 Dec;71(12):723-8.

PMID:
11906387
4.

Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.

Barth A, Craig PH, Silverstein MJ.

Cancer. 1997 May 15;79(10):1918-22.

PMID:
9149018
5.

A prospective validated model for predicting axillary node metastases based on 2,000 sentinel node procedures: the role of tumour location [corrected].

Bevilacqua J, Cody H 3rd, MacDonald KA, Tan LK, Borgen PI, Van Zee KJ.

Eur J Surg Oncol. 2002 Aug;28(5):490-500. Erratum in: Eur J Surg Oncol 2002 Dec;28(8):899.

PMID:
12217300
6.

Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma.

Yenidunya S, Bayrak R, Haltas H.

Diagn Pathol. 2011 Mar 13;6:18. doi: 10.1186/1746-1596-6-18.

7.

Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice.

Yoshihara E, Smeets A, Laenen A, Reynders A, Soens J, Van Ongeval C, Moerman P, Paridaens R, Wildiers H, Neven P, Christiaens MR.

Breast. 2013 Jun;22(3):357-61. doi: 10.1016/j.breast.2012.09.003. Epub 2012 Sep 28.

PMID:
23022046
8.

Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases.

Nogami T, Shien T, Tanaka T, Nishiyama K, Mizoo T, Iwamto T, Ikeda H, Taira N, Doihara H, Miyoshi S.

Breast Cancer. 2014 Jan;21(1):58-65. doi: 10.1007/s12282-012-0350-5. Epub 2012 Mar 10.

PMID:
22407396
9.

A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women.

Greer LT, Rosman M, Charles Mylander W, Liang W, Buras RR, Chagpar AB, Edwards MJ, Tafra L.

Breast J. 2014 Mar-Apr;20(2):147-53. doi: 10.1111/tbj.12233. Epub 2014 Jan 30.

PMID:
24475876
10.

Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.

Braun M, Flucke U, Debald M, Walgenbach-Bruenagel G, Walgenbach KJ, Höller T, Pölcher M, Wolfgarten M, Sauerwald A, Keyver-Paik M, Kühr M, Büttner R, Kuhn W.

Breast Cancer Res Treat. 2008 Dec;112(3):503-11. doi: 10.1007/s10549-007-9875-2. Epub 2007 Dec 29.

PMID:
18165897
11.

Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery?

Yip CH, Taib NA, Tan GH, Ng KL, Yoong BK, Choo WY.

World J Surg. 2009 Jan;33(1):54-7. doi: 10.1007/s00268-008-9782-7.

PMID:
18958521
12.

The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection?

Wong JS, O'Neill A, Recht A, Schnitt SJ, Connolly JL, Silver B, Harris JR.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):133-7.

PMID:
10924982
13.

Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors.

González-Vela MC, Garijo MF, Fernández FA, Buelta L, Val-Bernal JF.

Pathol Res Pract. 1999;195(9):611-8.

PMID:
10507081
14.

Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor.

Wu JL, Tseng HS, Yang LH, Wu HK, Kuo SJ, Chen ST, Chen DR.

Med Sci Monit. 2014 Apr 8;20:577-81. doi: 10.12659/MSM.890345.

15.

Factors influencing axillary node metastasis in breast cancer.

Cetintaş SK, Kurt M, Ozkan L, Engin K, Gökgöz S, Taşdelen I.

Tumori. 2006 Sep-Oct;92(5):416-22.

PMID:
17168435
16.

Factors affecting axillary lymph node metastases in patients with T1 breast carcinoma.

Markopoulos C, Kouskos E, Gogas H, Mandas D, Kakisis J, Gogas J.

Am Surg. 2000 Nov;66(11):1011-3.

PMID:
11090007
17.

T1 breast cancer: identification of patients at low risk of axillary lymph node metastases.

Bader AA, Tio J, Petru E, Bühner M, Pfahlberg A, Volkholz H, Tulusan AH.

Breast Cancer Res Treat. 2002 Nov;76(1):11-7.

PMID:
12408371
18.

Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.

Witt A, Obwegeser R, Auerbach L, Tempfer C, Yavuz D, Kubista E.

Wien Klin Wochenschr. 2002 Jun 14;114(10-11):387-90.

PMID:
12708092
19.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
20.

Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?

Anan K, Mitsuyama S, Tamae K, Nishihara K, Iwashita T, Abe Y, Ihara T, Toyoshima S.

Eur J Surg. 2000 Aug;166(8):610-5.

PMID:
11003428
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk